Zhongchao (ZCMD) Total Non-Current Liabilities (2021 - 2022)
Zhongchao (ZCMD) reported Total Non-Current Liabilities of -$31.6 million for Q4 2022, up 3.0% year-over-year from -$30.7 million in Q4 2021, and up 3.0% quarter-over-quarter from -$32.6 million in Q4 2021.
Zhongchao (ZCMD) Total Non-Current Liabilities (2021 - 2022) Analysis & Trends
Zhongchao (ZCMD) has 2 years of Total Non-Current Liabilities data on file, last reported at -$31.6 million in Q4 2022.
- Total Non-Current Liabilities for Q4 2022 came in at -$31.6 million, up 3.0% year-over-year; the trailing twelve-month figure through Dec 2022 was -$31.6 million (up 3.0% YoY), and the FY2022 annual result was -$31.6 million, up 3.0% from the prior year.
- Total Non-Current Liabilities climbed to -$31.6 million in Q4 2022 per ZCMD's latest filing, from -$32.6 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at -$31.6 million in Q4 2022 and troughed at -$32.6 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 1.79 Bn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 4.20 Bn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 1.12 Bn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 200.21 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 172.85 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 1.90 Bn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 10.69 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 737.31 Mn |
| 10 | Zhongchao | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -31.59 Mn |
| Dec 31, 2021 | -32.57 Mn |